Hepregen's Grant

Hepregen raised a round of funding on January 18, 2010. Investors include National Science Foundation.

Hepregen, a spinout of MIT, is developing a platform to reduce the liver toxicity caused by approved drugs. The platform is based on technology developed by Sangeeta Bhatia, an associate professor in …

Articles about Hepregen's Grant: